Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: J Pharm Sci. 2009 Sep;98(9):3167–3181. doi: 10.1002/jps.21719

Table 1.

Concentration (mg/mL) of anti-SA in different formulation before and after filtration *

Formulation Concn. Unfiltered (mg/mL) Concn. In Aqueous Filtrate (mg/mL) Difference in Concn. pre and post filtration (mg/mL)**
A5 1.02 ± 0.04 1.02 ± 0.04 0.01 ± 0.01
A5NaCL 1.00 ± 0.01 0.94 ± 0.03 0.06 ± 0.02
Phosphate 0.99 ± 0.02 0.95 ± 0.05 0.04 ± 0.02
PBS 1.02 ± 0.01 0.98 ± 0.03 0.04 ± 0.02
A5 polysorbate20 0.99 ± 0.02 0.98 ± 0.01 0.01± 0.01
A5 sucrose 1.04 ± 0.03 0.99 ± 0.04 0.03 ± 0.01
*

The mean ± SD was calculated from triplicate set of samples each replicate prepared using different syringes and filter.

**

The mean ± SD was calculated from differences in concentration measured for each replicate for a given solution.